# Prometheus Biosciences, Inc.

Prometheus Biosciences, Inc. is a company headquartered in San Diego, CA, United States.

## Company overview

- **Legal name:** Prometheus Biosciences, Inc.
- **Former names in filing history:** Precision IBD, Inc. (2017-10-10 to 2019-07-15)
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** San Diego, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001718852

## About

Prometheus Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001718852, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-02-28, it reported annual revenue of USD 6,809,000; net income of USD -141,752,000; total assets of USD 740,773,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-12-31)

- **Revenue:** $6.8M (USD 6,809,000)
- **Net income:** -$141.8M (USD -141,752,000)
- **Total assets:** $740.8M (USD 740,773,000)
- **Cash and equivalents:** $292.4M (USD 292,423,000)
- **Operating cash flow:** -$123.3M (USD -123,254,000)

### FY2021 (period ended 2021-12-31)

- **Revenue:** $3.1M (USD 3,129,000)
- **Net income:** -$90.2M (USD -90,195,000)
- **Total assets:** $267.8M (USD 267,801,000)
- **Cash and equivalents:** $257.3M (USD 257,254,000)
- **Operating cash flow:** -$63.5M (USD -63,505,000)

## Recent SEC filings

- Form 8-K — filed 2023-06-16 — period 2023-06-16 — 8-K
- Form 8-K — filed 2023-06-15 — period 2023-06-15 — 8-K
- Form 8-K — filed 2023-05-23 — period 2023-05-22 — 8-K
- Form 10-Q — filed 2023-05-09 — period 2023-03-31 — 10-Q
- Form 8-K — filed 2023-05-09 — period 2023-05-09 — 8-K
- Form 10-K/A — filed 2023-04-28 — period 2022-12-31 — 10-K/A
- Form 8-K — filed 2023-04-17 — period 2023-04-15 — 8-K
- Form 8-K — filed 2023-03-10 — period 2023-03-10 — 8-K
- Form 10-K — filed 2023-02-28 — period 2022-12-31 — 10-K
- Form 8-K — filed 2023-02-28 — period 2023-02-28 — 8-K
- Form SC 13G — filed 2023-02-03
- Form 8-K — filed 2022-12-09 — period 2022-12-08 — 8-K

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/prometheus-biosciences-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology